Dr Chong-Yee Khoo has been invited to be part of an expert panel on Asia Pacific Intellectual Property at this year’s CIPA Life Sciences Conference.
Chong-Yee will cover biotech patent law in Singapore, Malaysia, Thailand, Indonesia and Japan.
The Asia Pacific IP Panel aims to inform delegates about the boundaries of protection and main issues that may arise in life sciences patent cases in the various jurisdictions. Topics for discussion include:
- Method of treatment and second medical use (“Swiss format”) claims and latest legal decisions
- Changes in the law that affect biotech and pharma claiming and enforcement
- Patent term extension regulations in the region
- Are gene and protein sequences patentable per se?
- Are there any moves to require disclosure of origin for genetic material?
This year’s conference will also include talks on United Kingdom, European Patent Office and United States patent law updates, litigation strategies and recent changes in the UK, Europe and US, a panel discussion on hot tpoics in pharmaceuticals as well as a scientific presentation.
This year’s pre-dinner talk will be from Lord Kitchin.
The CIPA Life Sciences Conference is described as “the UK’s premier annual educational and networking event for patent and IP professionals active in the pharma, medical technology and biotechnology sectors”. The Conference is organised by the Life Sciences Committee of the Chartered Institute of Patent Attorneys, UK
Over nearly two decades the Life Sciences Conference (previously known as the CIPA Biotech Conference) has provided unrivalled expert insight into the latest developments in patents, regulatory and IP law in the global life science industry. Most importantly, the event provides a friendly environment for in-house and private practice professionals to network and share experiences.
The CIPA Life Sciences Conference will be held at the Grand Hotel, Brighton on 11 and 12 November 2019. We hope to see you there.